abstract |
The present invention relates to methods for preventing or treating human immunodeficiency virus (HIV) infection, inflammatory conditions and graft versus host disease (GVHD) in a subject. The therapeutic compositions of the present invention comprise leucocidin E (LuKe) and / or D proteins or polypeptides. The invention also relates to methods for treating Staphylococcus aureus infection by administering a composition comprising a CCR5 antagonist or any molecule that blocks the interaction. of LuKe / D with CCR5 'cells in an amount effective to treat S. aureus infection in the subject. |